tm logo

Monitor this mark

View On USPTO

TYSABRI
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 10 Mar 2021

Last Applicant/ Owned by

BIOGEN MA INC.

225 Binney Street

Cambridge

MA

02142

Serial Number

86331909 filed on 09th Jul 2014

Registration Number

4671846 registered on 13th Jan 2015

in the Principal Register

Correspondent Address

Douglas A. Rettew

Douglas A. Rettew Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Washington, DC 20001

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

TYSABRI

Pharmaceutical preparations for the treatment of neurologic disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of neurologic disorders

First Use Date in General

30th Nov 2004

First Use Date in Commerce

30th Nov 2004

Mark Details

Serial Number

No 86331909

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 14726.0166-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
02th Oct 2024TEAS SECTION 8 & 9 RECEIVED
13th Jan 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10th Mar 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Mar 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10th Mar 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03rd Dec 2020TEAS SECTION 8 & 15 RECEIVED
13th Jan 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06th Nov 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
01st Apr 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13th Jan 2015REGISTERED-PRINCIPAL REGISTER